Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20090Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ioannidis, J. P. | en |
| dc.contributor.author | Contopoulos-Ioannidis, D. G. | en |
| dc.contributor.author | Chew, P. | en |
| dc.contributor.author | Lau, J. | en |
| dc.date.accessioned | 2015-11-24T19:04:42Z | - |
| dc.date.available | 2015-11-24T19:04:42Z | - |
| dc.identifier.issn | 0305-7453 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20090 | - |
| dc.rights | Default Licence | - |
| dc.subject | Acute Disease | en |
| dc.subject | Anti-Bacterial Agents/adverse effects/*therapeutic use | en |
| dc.subject | Azithromycin/adverse effects/*therapeutic use | en |
| dc.subject | Chi-Square Distribution | en |
| dc.subject | Confidence Intervals | en |
| dc.subject | Humans | en |
| dc.subject | Odds Ratio | en |
| dc.subject | Otitis Media/diagnosis/drug therapy | en |
| dc.subject | Pharyngitis/diagnosis/drug therapy | en |
| dc.subject | Randomized Controlled Trials as Topic/*statistics & numerical data | en |
| dc.subject | Respiratory Tract Infections/diagnosis/*drug therapy | en |
| dc.subject | Sinusitis/diagnosis/drug therapy | en |
| dc.title | Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/11679557 | - |
| heal.identifier.secondary | http://jac.oxfordjournals.org/content/48/5/677.full.pdf | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2001 | - |
| heal.abstract | We carried out a meta-analysis of randomized controlled trials comparing 3-5 days of azithromycin with other antibiotics that are typically given in longer courses for the treatment of upper respiratory tract infections. For acute otitis media (19 comparisons including 3421 patients), acute sinusitis (11 comparisons including 1742 patients) and acute pharyngitis (16 comparisons including 2447 patients), azithromycin had similar clinical failure rates to the other antibiotics [random effects odds ratios 1.12, 95% confidence interval (CI) 0.81-1.54; 0.91, 95% CI 0.60-1.39; and 1.07, 95% CI 0.59-1.94, respectively]. The difference in clinical failures was <0.5%, and no 95% CIs exceeded 2.0%. There was no heterogeneity between studies. Subtle differences between comparators could have been due to chance. There were no significant differences in bacteriological outcomes. Azithromycin was discontinued because of adverse events in only 37 of 4870 (0.8%) patients. Short courses of azithromycin are as effective as longer courses of other antibiotics for upper respiratory tract infections. Convenience of dosing should be balanced against the increased cost of this regimen for the treatment of these common infections, where often no antibiotic may be indicated at all. | en |
| heal.journalName | J Antimicrob Chemother | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Ioannidis-2001-Meta-analysis of ran.pdf | 217.63 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
